Alector Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Alector Stock Summary

Alector competes with Passage Bio, Black Diamond, Revolution Medicines, Stoke Therapeutics, and Monte Rosa. Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. The company was founded in 2013 and is headquartered in South San Francisco, California. Alector operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 269 people.

Alector Key Financial Ratios

Alector Key Balance Sheet Accounts

Alector Key Cash Accounts

Alector Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alector's current stock value. Our valuation model uses many indicators to compare Alector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alector competition to find correlations between indicators driving Alector's intrinsic value. More Info.Alector is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . At present, Alector's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alector's earnings, one of the primary drivers of an investment's value.

Alector Systematic Risk

Today, most investors in Alector Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alector's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alector growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Alector help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alector. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alector based on widely used predictive technical indicators. In general, we focus on analyzing Alector Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alector's daily price indicators and compare them against related drivers.

When running Alector's price analysis, check to measure Alector's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alector is operating at the current time. Most of Alector's value examination focuses on studying past and present price action to predict the probability of Alector's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alector's price. Additionally, you may evaluate how the addition of Alector to your portfolios can decrease your overall portfolio volatility.